RecruitingNCT06553625

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System


Sponsor

Boston Scientific Corporation

Enrollment

200 participants

Start Date

Jan 29, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems used in the central nervous system (CNS) for use in functional neurosurgery.


Eligibility

Plain Language Summary

Simplified for easier understanding

This observational study (RAPID for CNS) is collecting real-world outcomes from patients who are treated with a radiofrequency (RF) ablation system made by Boston Scientific for pain or conditions affecting the central nervous system. RF ablation uses heat to disrupt nerve signals and reduce pain. **You may be eligible if...** - You are scheduled to receive treatment with a Boston Scientific RF ablation system, per your doctor's plan - You have signed an informed consent form **You may NOT be eligible if...** - You have a condition that is listed as a contraindication for the RF device - You have cognitive impairment or another issue that would prevent you from completing pain assessment questionnaires Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERadiofrequency Ablation

Radiofrequency Ablation used in the central nervous system (CNS) in functional neurosurgery


Locations(4)

Uniklinik Köln

Cologne, Germany

Universitaetsklinikum Dusseldorf

Düsseldorf, Germany

Universitaetsklinikum Wuerzburg

Würzburg, Germany

St. Georges Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06553625


Related Trials